Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Microcrystalline Hydroxyapatite (Ossein-Hydroxyapatite Compound)
A calcium source made from bovine bone, supplying calcium and phosphorus as hydroxyapatite together with collagen and other bone matrix proteins.
What the evidence says
Hydroxyapatite (MCHC) doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from medium-quality meta-analyses and randomised trials published 1984–2026 with a typical study size of 62 participants.
Based on 18 studies · 1 meta-analysis · 11 RCTs · 1,860 total participants
Study base
18 studies indexedBy outcome
Every outcome below: Too few graded studies.
One 2009 meta-analysis of six trials found bone density held up 1.02% better with ossein-hydroxyapatite compound than with calcium carbonate (95% CI 0.63-1.41), and a 3-year cohort of 851 women points the same way. But the comparator in almost every trial is another calcium salt, the trials are small and mostly open-label, several authors recur across the trials and the meta-analysis, and a fracture-prevention benefit has not been shown. The one double-blind placebo-controlled trial found no significant bone density change at 6 months, and in an independent randomised trial bone turnover fell by similar amounts as with ordinary calcium (no between-group difference is reported in the abstract). It is a calcium source with a small surrogate edge over carbonate, not a proven bone-protecting agent in its own right.
11 randomised trials
100% were about Hydroxyapatite (MCHC) in an audit of 11 of them
Every randomised or controlled trial of Hydroxyapatite (MCHC) indexed in PubMed, not a hand-picked subset. Meta-analyses and systematic reviews are deliberately excluded from this count: most of them cover many compounds at once, so counting them would inflate it.
PubMed · as of Oct 2026
Microcrystalline hydroxyapatite compound, also called ossein-hydroxyapatite compound or complex, is made from bovine bone.
It supplies calcium and phosphorus in the crystal form bone itself uses, together with the organic bone matrix (ossein): type I collagen and non-collagenous proteins and peptides, including small amounts of growth factors.
It is taken as a calcium source for bone health, and in some countries it is licensed as a medicine for preventing bone loss. Most trials compare it with calcium carbonate rather than with placebo.
A 2009 meta-analysis of six such trials found bone density held up about 1% better with the hydroxyapatite compound, and later open-label and observational studies point the same way.
The trials are small, mostly unblinded and largely from one research network, they measure bone density, a fracture-prevention benefit has not been shown, and the one double-blind placebo-controlled trial found no significant change in bone density at 6 months.
In an independent trial bone turnover fell by similar amounts with it and with ordinary calcium (no between-group difference is reported in the abstract), while blood calcium rose less, and in a randomised comparison of five calcium salts it lowered parathyroid hormone significantly less than the others.
Because the active is calcium, the same upper limits, drug spacing rules and kidney cautions apply as for any calcium supplement.
Supplies calcium together with phosphorus in the hydroxyapatite crystal form that makes up bone mineral. In one trial it raised serum phosphate and the calcium-phosphate product, which conventional calcium salts did not.
In a randomised trial in postmenopausal women, a dose of microcrystalline hydroxyapatite raised ionised calcium less than the same calcium dose as citrate or carbonate, while bone turnover fell by similar amounts (no between-group difference is reported in the abstract).
All calcium sources lower parathyroid hormone acutely, which reduces the drive to resorb bone. In a randomised comparison of five calcium salts in healthy men, the ossein-hydroxyapatite compound lowered parathyroid hormone significantly less than calcium carbonate or citrate, and less than the other two salts tested, though still more than an inactive vehicle. A 2-year controlled trial in corticosteroid-treated patients reported biochemistry "suggestive of a reduction in parathyroid over-activity".
The ossein fraction contains type I collagen and non-collagenous proteins, including small amounts of IGF-I, IGF-II, TGF-beta and osteocalcin. Trial authors suggest this explains results beyond the calcium dose, but that these proteins act on bone after being swallowed has not been shown in humans.
The population most studied. Trials show slightly better bone density maintenance than calcium carbonate, but a fracture-prevention benefit has not been shown. Usually combined with adequate vitamin D.
Calcium itself is appropriate in pregnancy when it is needed, but this bone-derived form has one trial of 20 heparin-treated women, which does not establish safety for all pregnancies. Prefer a conventional calcium preparation unless a clinician advises otherwise, and check the total elemental calcium and the product quality.
Not studied in lactation. A conventional calcium preparation is the better-characterised choice. Check the total elemental calcium and the product quality.
Use only under medical supervision. It supplies both calcium and phosphate, and raised the calcium-phosphate product in one trial.
Not suitable. It is made from bovine bone. Calcium citrate or carbonate supply the same mineral.
Small older trials studied this product to limit drug-induced bone loss, and some results were not statistically significant. Preventing bone loss in these groups should be planned by a clinician.
Calcium and other minerals can reduce the absorption of a bisphosphonate taken by mouth. Follow the instructions for the exact medicine and formulation, and ask your pharmacist when to take this calcium supplement. Oral alendronate must be taken with plain water at least 30 minutes before food, other drinks or medicines; other formulations have different instructions. This absorption and spacing instruction does not apply to a bisphosphonate given by injection or infusion. A grade for this interaction is held for clinical review and has not been validated, so no severity is given. The precaution still applies: ask a pharmacist about the exact supplement and medicine. Do not stop or change prescribed medicines based on this notice.
This calcium-containing product may reduce oral levothyroxine absorption. Follow the timing and order for the exact levothyroxine preparation; ask a pharmacist if unsure. A grade for this interaction is held for clinical review and has not been validated, so no severity is given. The precaution still applies: ask a pharmacist about the exact supplement and medicine. Do not stop or change prescribed medicines based on this notice.
Calcium chelates tetracyclines and reduces their absorption. Ask the pharmacist to schedule this calcium supplement apart from the antibiotic, following that antibiotic's label.
Calcium can reduce the absorption of some fluoroquinolones taken by mouth, but the effect and any required interval depend on the exact antibiotic and product. Ask your pharmacist whether separation is needed and follow that medicine’s label. This gut-absorption interaction does not apply to an antibiotic given into a vein. A grade for this interaction is held for clinical review and has not been validated, so no severity is given. The precaution still applies: ask a pharmacist about the exact supplement and medicine. Do not stop or change prescribed medicines based on this notice.
Calcium lowers non-heme iron absorption from a dose taken at the same time. When treating iron deficiency, take them at different times of day.
Thiazides reduce urinary calcium loss, so added calcium can raise blood calcium. Monitor serum calcium.
Loop diuretics increase urinary calcium excretion, potentially increasing calcium requirements.
Long-term corticosteroid use decreases intestinal calcium absorption and increases urinary excretion. Higher calcium intake may be needed.
High blood calcium can increase susceptibility to digoxin toxicity. Avoid excessive supplementation and have calcium and renal function assessed when indicated.
Chronic use increases vitamin D catabolism, reducing calcium absorption. Increased calcium and vitamin D may be needed.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: If you develop a new or unexpected symptom, pause this optional product and seek advice before trying a lower dose, a different schedule or an added remedy. Follow any urgent instructions for the symptom now.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Tip: Take with meals
Tip: Stay hydrated and keep total calcium within the upper limit
Tip: Count calcium from all supplements and food against the upper limit
Tip: Avoid with a beef or bovine protein allergy
Hydroxyapatite (MCHC) has an evidence score of 4.5/10 — emerging evidence based on 18 indexed studies, including 1 meta-analysis. A calcium source made from bovine bone, supplying calcium and phosphorus as hydroxyapatite together with collagen and other bone matrix proteins. Representative study: PMID 19407667.
The best time to take Hydroxyapatite (MCHC) is in split doses through the day. Take it with food. Trials gave the compound twice daily.
Hydroxyapatite (MCHC) has a safety rating of "moderate". That is a category, not a measure of individual risk, and there are precautions worth knowing. Selected serious risks: hypercalcaemia at excessive total calcium intake. How often they occur is not established for all of them. Reported side effects include kidney stones (calcium-containing), allergic reaction in people sensitive to bovine proteins. How often they occur is not established for all of them. Use caution if any of these apply to you: Hypercalcaemia (raised blood calcium); Hypercalciuria or a history of calcium kidney stones without medical supervision; Severe kidney impairment, where both the calcium and the phosphate it supplies can accumulate.
What side effects does Hydroxyapatite (MCHC) have?Don't take this if…
Magnesium
No clear benefitSupports 300+ enzymatic reactions — critical for sleep, stress response, muscle function, and cognitive health.
Zinc
HelpedInvolved in 300+ enzymatic reactions — supports immune defense, testosterone production, wound healing, and sleep quality.
Boron
Too few graded studiesTrace mineral. In small human studies, low boron intake gave poorer attention and memory, and one week of boron raised free testosterone in 8 men. Benefits from supplements are not established.
Calcium
HelpedBuilds and maintains bone density while supporting muscle contraction, nerve signaling, and cardiovascular function.
Explore: Best supplements for Body Health
Edited by Dr. Baher Al Hakim · Last updated November 2026 · evidence from 18 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.